4//SEC Filing
ONSI DOUGLAS E 4
Accession 0001104659-23-035047
CIK 0001509745other
Filed
Mar 20, 8:00 PM ET
Accepted
Mar 21, 4:05 PM ET
Size
8.7 KB
Accession
0001104659-23-035047
Insider Transaction Report
Form 4
ONSI DOUGLAS E
DirectorCEO,CFO,Pres.,GC,Treas.&Sec.
Transactions
- Exercise/Conversion
Common Stock
2023-03-17+660,606→ 661,466 total - Exercise/Conversion
Restricted Stock Units
2023-03-17−660,606→ 0 total→ Common Stock (660,606 underlying)
Holdings
- 4,144,804(indirect: By HealthCare Ventures IX, L.P.)
Common Stock
Footnotes (3)
- [F1]Restricted Stock Units convert into common stock on a one-for-one basis.
- [F2]The reporting person is a Managing Director of HealthCare Partners IX, LLC which is the General Partner of HealthCare Partners IX, L.P., which is the General Partner of HealthCare Ventures IX, L.P. The reporting person beneficially owns and shares voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and disclaims beneficial ownership of these shares except to the extent of his proportionate pecuniary interest therein.
- [F3]On March 17, 2020, the reporting person was granted 660,606 Restricted Stock Units, vesting on March 17, 2023 or upon a change of control, whichever is earlier, provided that the grantee continues to be employed by, or provides service to the Company from the grant date to the vesting date of the Restricted Stock Units. At such time as the Restricted Stock Units vest, one share of Common Stock shall be issued automatically in settlement of each Restricted Stock Unit.
Documents
Issuer
LEAP THERAPEUTICS, INC.
CIK 0001509745
Entity typeother
Related Parties
1- filerCIK 0001270185
Filing Metadata
- Form type
- 4
- Filed
- Mar 20, 8:00 PM ET
- Accepted
- Mar 21, 4:05 PM ET
- Size
- 8.7 KB